Redeye comments on a new additional supplier of Terbinafine that already holds an EU certificate of Suitability. This is positive as it confirms that Moberg Pharma is on track to secure enough Terbinafine for the wide EU launch, which is still projected to happen in 2026e.
LÄS MER